Schubert & Co’s CVS Health CVS Stock Holding History

Schubert & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-167	Closed	-$12.4K	–	406
2023 Q1	$12.4K	Sell	167 -100	-37%	-$8.39K	0.01%	188
2022 Q4	$24.9K	Sell	267 -26	-9%	-$2.51K	0.02%	96
2022 Q3	$28K	Buy	293 +50	+21%	+$4.95K	0.03%	87
2022 Q2	$23K	Buy	243 +54	+29%	+$5.27K	0.02%	102
2022 Q1	$19K	Buy	189 +126	+200%	+$13.2K	0.02%	85
2021 Q4	$6K	Buy	+63	New	+$5.82K	0.01%	122

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Schubert & Co's CVS Position: Q2 2023 in Review

Schubert & Co sold out of CVS Health (CVS) in Q2 2023, closing a stake of 167 shares — an estimated $12.4K sold.

Schubert & Co first reported a position in CVS in Q4 2021 and held it in 6 quarters. The position peaked at $28K in Q3 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Schubert & Co reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 167 CVS Health shares in Q2 2023, an estimated $12.4K.
Schubert & Co first reported a position in CVS Health in Q4 2021 and held it in 6 quarters.
Schubert & Co's CVS Health position peaked at $28K in Q3 2022.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.